Skip to main content

PT Tempo Scan Pacific Tbk (TSPC.JK)

Indonesia Stock Exchange Healthcare Drug Manufacturers - Specialty & GenericView data quality →
70.7Good

ValueMarkers Composite Index

Top 99%#290 of 44,722
Undervalued

63% below intrinsic value ($0)

UndervaluedFair ValueOvervalued
Piotroski
7/9
Strong
Beneish
-2.44
Low Risk
Altman
4.97
Safe
DCF Value
$0
Undervalued
ROIC
12.0%
Adequate
P/E
7.8
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

PT Tempo Scan Pacific Tbk (TSPC.JK) — VMCI valuation read

The headline on PT Tempo Scan Pacific Tbk (TSPC.JK) is a 71/100 VMCI score, set against a Healthcare sector median of 50. That 21-point above-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value tailwind is in the data.

TSPC.JK insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** TSPC.JK trades at 17.0x earnings, 6% below the Healthcare median of 18.0x sets the value side. ROIC of 15.0% sits 5.0pp above the Healthcare median (10.0%) sets the quality side. Net debt to EBITDA of 3.5x is the binding constraint on the bear case sets the risk side, the three lines a value buyer reads first on TSPC.JK.

TSPC.JK rose 0.6% over the trailing 7 days, with a -15.4% read on a 30-day basis.

PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through three segments: Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and beverages, and plastic packaging; and manufacturing and trading of consumer products, cosmetics, and household products. The company sells its products under the Bodrex, Oskadon, Neo rheumacyl, Bodrexin, Contrexyn, Contrex, Oskadryl, Vidoran, Neodulax, Vidoran, Hemaviton, Neo Hormoviton, Polaris, Vitonal, Vitamin IPI, Neo rheumacyl Herbal, Wybert Herbal, Bodrexin Herbal, Herbalax, Marina, Natural Honey, Claudia, MY BABY, MY BABY Kids, Pure Baby, S.O.S, Total Care, and ULTIMA II brands. It also engages in the construction and rental of buildings; provision of warehousing, freight forwarding, advertising and promotion, research and development, and information technology and communication network systems services; and procurement, distribution, and marketing activities. The company was formerly known as PT Scanchemie. The company was founded in 1970 and is headquartered in Jakarta, Indonesia. PT Tempo Scan Pacific Tbk is a subsidiary of PT Bogamulia Nagadi.

CEO: I Made Dharma Wijaya4,460 employeesIDwww.temposcangroup.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.